Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luxin Yang

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
British Journal of Haematology|June 4, 2025
Higher risk of platelet engraftment failure and chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation following chimeric antigen receptor T-cell therapy compared to chemotherapy: A propensity score-matched analysisLuxin Yang, Xiaoyu Lai, Lizhen Liu, et al.
Open Forum Infectious Diseases|March 14, 2024
Characteristics of Coronavirus Disease in Allogeneic Hematopoietic Stem Cell Transplantation During the Omicron Wave: A Single-Center StudyPanpan Zhu, Luxin Yang, Lizhen Liu, et al.
British Journal of Haematology|August 25, 2023
Double filtration plasmapheresis combined with rituximab for donor-specific antibody desensitization in haploidentical haematopoietic stem cell transplantationLizhen Liu, Xinyu Ji, Panpan Zhu, et al.
Bone Marrow Transplantation|May 2, 2018
Allogeneic hematopoietic stem cell transplantation should be in preference to conventional chemotherapy as post-remission treatment for adults with lymphoblastic lymphomaLuxin Yang, Yamin Tan, Jimin Shi, et al.
Bone Marrow Transplantation|June 17, 2020
Correction: Allogeneic hematopoietic stem cell transplantation should be in preference to conventional chemotherapy as post-remission treatment for adults with lymphoblastic lymphomaLuxin Yang, Yamin Tan, Jimin Shi, et al.
Cell Transplantation|June 13, 2026
Pre-transplant <i>Clostridioides difficile</i> infection predicts subsequent gastrointestinal GVHD and non-relapse mortality after allogeneic hematopoietic stem cell transplantationWenyi Wang, Yibo Wu, Yunbo Chen, et al.
Clinical & Translational Immunology|January 15, 2024
Graft CD8 T-cell-based risk system predicts survival in antithymocyte globulin-based myeloablative haploidentical peripheral blood stem cell transplantationPanpan Zhu, Luxin Yang, Yibo Wu, et al.
Cell Transplantation|June 25, 2025
Prognostic effect of body mass index in patients with acute leukemia undergoing allogeneic hematopoietic stem cell transplantation: A retrospective cohort studyJing Yu, Zhuoyue Shi, Hengwei Wu, et al.
Journal of Translational Medicine|March 14, 2024
Impact of myelofibrosis on patients with myelodysplastic syndromes following allogeneic hematopoietic stem cell transplantationPanpan Zhu, Xiaoyu Lai, Lizhen Liu, et al.
Transplantation and Cellular Therapy|March 1, 2022
Impact of Donor-to-Recipient ABO Mismatch on Outcomes of Antithymocyte Globulin-Based Peripheral Blood Stem Cell-Derived Myeloablative Conditioning Haploidentical Stem Cell TransplantationYibo Wu, Lihong Ni, Yan Liu, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
British Journal of Haematology|June 4, 2025
Higher risk of platelet engraftment failure and chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation following chimeric antigen receptor T-cell therapy compared to chemotherapy: A propensity score-matched analysisLuxin Yang, Xiaoyu Lai, Lizhen Liu, et al.
Open Forum Infectious Diseases|March 14, 2024
Characteristics of Coronavirus Disease in Allogeneic Hematopoietic Stem Cell Transplantation During the Omicron Wave: A Single-Center StudyPanpan Zhu, Luxin Yang, Lizhen Liu, et al.
British Journal of Haematology|August 25, 2023
Double filtration plasmapheresis combined with rituximab for donor-specific antibody desensitization in haploidentical haematopoietic stem cell transplantationLizhen Liu, Xinyu Ji, Panpan Zhu, et al.
Bone Marrow Transplantation|May 2, 2018
Allogeneic hematopoietic stem cell transplantation should be in preference to conventional chemotherapy as post-remission treatment for adults with lymphoblastic lymphomaLuxin Yang, Yamin Tan, Jimin Shi, et al.
Bone Marrow Transplantation|June 17, 2020
Correction: Allogeneic hematopoietic stem cell transplantation should be in preference to conventional chemotherapy as post-remission treatment for adults with lymphoblastic lymphomaLuxin Yang, Yamin Tan, Jimin Shi, et al.
Cell Transplantation|June 13, 2026
Pre-transplant <i>Clostridioides difficile</i> infection predicts subsequent gastrointestinal GVHD and non-relapse mortality after allogeneic hematopoietic stem cell transplantationWenyi Wang, Yibo Wu, Yunbo Chen, et al.
Clinical & Translational Immunology|January 15, 2024
Graft CD8 T-cell-based risk system predicts survival in antithymocyte globulin-based myeloablative haploidentical peripheral blood stem cell transplantationPanpan Zhu, Luxin Yang, Yibo Wu, et al.
Cell Transplantation|June 25, 2025
Prognostic effect of body mass index in patients with acute leukemia undergoing allogeneic hematopoietic stem cell transplantation: A retrospective cohort studyJing Yu, Zhuoyue Shi, Hengwei Wu, et al.
Journal of Translational Medicine|March 14, 2024
Impact of myelofibrosis on patients with myelodysplastic syndromes following allogeneic hematopoietic stem cell transplantationPanpan Zhu, Xiaoyu Lai, Lizhen Liu, et al.
Transplantation and Cellular Therapy|March 1, 2022
Impact of Donor-to-Recipient ABO Mismatch on Outcomes of Antithymocyte Globulin-Based Peripheral Blood Stem Cell-Derived Myeloablative Conditioning Haploidentical Stem Cell TransplantationYibo Wu, Lihong Ni, Yan Liu, et al.
Pageof 7